Acquisitions and Divestitures - Divestitures (Details) - USD ($) $ in Millions |
3 Months Ended | 7 Months Ended | 9 Months Ended | 12 Months Ended | |
|---|---|---|---|---|---|
Aug. 12, 2026 |
Sep. 26, 2026 |
Aug. 12, 2026 |
Sep. 26, 2026 |
Dec. 31, 2025 |
|
| Disposed of by sale | Microbiology Business | |||||
| Disposal Group, Including Discontinued Operations [Line Items] | |||||
| Disposal consideration | $ 1,070 | $ 1,070 | |||
| Gain (loss) on disposal | $ 72 | $ 72 | |||
| Net of retained sales | $ 294 | $ 476 | |||
| Held for sale | Pharma Services Manufacturing Facility | |||||
| Disposal Group, Including Discontinued Operations [Line Items] | |||||
| Gain (loss) on disposal | $ (244) |
| X | ||||||||||
- Definition Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|